Bank of Montreal
RVMD icon

Bank of Montreal’s Revolution Medicines RVMD Stock Holding History

Bank of Montreal’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.33M Sell
23,103
-159
-0.7% -$23.2K ﹤0.01% 1429
2026
Q1 		$2.26M Buy
23,262
+20,514
+747% +$2.07M ﹤0.01% 1612
2025
Q4 		$219K Buy
+2,748
New +$180K ﹤0.01% 2796
2024
Q2 		– Sell
-27,904
Closed -$903K – 4188
2024
Q1 		$903K Buy
+27,904
New +$827K ﹤0.01% 2064
2022
Q4 		– Sell
-104
Closed -$2K – 4241
2022
Q3 		$2K Sell
104
-87,949
-100% -$1.93M ﹤0.01% 3991
2022
Q2 		$1.68M Buy
+88,053
New +$1.71M ﹤0.01% 1989
2021
Q2 		– Sell
-1,593
Closed -$72K – 4718
2021
Q1 		$72K Sell
1,593
-4,426
-74% -$198K ﹤0.01% 3549
2020
Q4 		$232K Buy
6,019
+4,177
+227% +$165K ﹤0.01% 3150
2020
Q3 		$73K Buy
1,842
+625
+51% +$17.3K ﹤0.01% 3254
2020
Q2 		$33K Buy
+1,217
New +$38.3K ﹤0.01% 3624

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bank of Montreal's RVMD Position: Q2 2026 in Review

Bank of Montreal reduced its Revolution Medicines (RVMD) stake by 0.68% in Q2 2026, selling an estimated $23.2K and leaving 23,103 shares worth $4.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1429.

Bank of Montreal first reported a position in RVMD in Q2 2020 and has held it in 10 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Bank of Montreal held 23,103 shares of Revolution Medicines worth $4.33M as of Q2 2026.
  • Bank of Montreal sold 159 Revolution Medicines shares in Q2 2026, an estimated $23.2K.
  • Revolution Medicines made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1429 holding.
  • Bank of Montreal first reported a position in Revolution Medicines in Q2 2020 and has held it in 10 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.